John R. Inglis - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock John R. Inglis's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
John R. Inglis
Verified
Co-Founder, bioRxiv
New York
Beats
All of ophthalmology
Content
Company Info
bioRxiv
bioRxiv and medRxiv are prominent open-access preprint servers for biological and medical research, respectively. Founded in 2013 and 2019, these non-profit platforms allow researchers to share preliminary findings before formal peer review. In 2025, they transitioned to openRxiv to ensure their long-term sustainability and growth. The services offered include free submission and distribution of unpublished manuscripts, light moderation for scientific validity and ethical compliance, and community engagement through open commenting. bioRxiv focuses on biological sciences, while medRxiv is dedicated to medical and clinical research. Researchers, institutions, publishers, and funders benefit from these platforms, which enhance visibility and collaboration in the scientific community. The mission of bioRxiv and medRxiv is to improve scientific transparency, reduce publication delays, and democratize access to research globally.
New York, , United States
Founded: 2013